MD Anderson Research Highlights for April 24, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research...
MD Anderson Research Highlights for April 12, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research...
AACR: Combination treatment is well-tolerated, shows...
Combining the KRAS G12C inhibitor adagrasib with the anti-EGFR antibody cetuximab demonstrated promising anti-tumor effects in...
AACR: Novel immunotherapies show promise for patients with kidney...
Researchers from The University of Texas MD Anderson Cancer Center presented encouraging findings today from two clinical trials in a...
MD Anderson Research Highlights AACR 2024 Special Edition
ABSTRACTS: 1212, 1227, 1244, 1283, CT030, 3893, 3922, 3930, 3942, 6620
The University of Texas MD Anderson Cancer Center’s Research...